ALTIUM CAPITAL
Altium Capital is a healthcare investment firm focusing on the development of stage public mid-and small-cap equities. It focuses on identifying opportunities to invest in growth companies in the healthcare industry. Founded in 2017 by Jacob Gottlieb, Altium Capital is headquartered in New York.
ALTIUM CAPITAL
Industry:
Financial Services Health Care Hedge Funds Impact Investing Medical Medical Device
Founded:
2017-06-30
Status:
Active
Contact:
212-259-8400
Technology used in webpage:
Euro U.S. Server Location
Similar Organizations
Aceras BioMedical
Aceras BioMedical is a healthcare investment firm that specializes in funding the development of novel medical innovations.
Affinity Asset Advisors
Affinity Asset Advisors is a healthcare-focused hedge fund with public and private investments
Alternate Health
Alternate Health is a healthcare investment company specializing in the software development for the healthcare industry.
Cain Brothers
Cain Brothers is a healthcare-focused investment firm offering advice on mergers and acquisitions.
D1 Capital Partners
D1 Capital Partners is an investment firm that deploys capital in both public and private markets.
Navo Capital
Navo Capital serves business, consumer and healthcare sectors with a focus on development to obtain private equity investments.
PACE Healthcare Capital
PACE Healthcare Capital is an early-stage VC firm, deploying financial and human capital, to support the healthcare of tomorrow.
United Medical Credit
We are a lending platform that connects Patients with Lenders by establishing and managing relationships with Provider offices.
Current Employees Featured
Mark Gottlieb COO @ Altium Capital
COO
2017-06-30
Jacob Gottlieb CEO @ Altium Capital
CEO
2018-01-01
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-03-13 | Cybin | Altium Capital investment in Post-IPO Equity - Cybin | 150 M USD |
| 2024-01-29 | Skye Bioscience | Altium Capital investment in Post-IPO Equity - Skye Bioscience | 50.25 M USD |
| 2024-01-23 | Outlook Therapeutics | Altium Capital investment in Post-IPO Equity - Outlook Therapeutics | 65 M USD |
| 2023-07-17 | Evogene | Altium Capital investment in Post-IPO Equity - Evogene | 8.5 M USD |
| 2022-02-24 | Aligned | Altium Capital investment in Seed Round - Aligned | 34 M USD |
| 2021-11-03 | Antios Therapeutics | Altium Capital investment in Series B - Antios Therapeutics | 75 M USD |
| 2021-09-03 | Renovacor | Altium Capital investment in Post-IPO Equity - Renovacor | 30 M USD |
| 2021-06-08 | Ocuphire Pharma | Altium Capital investment in Post-IPO Equity - Ocuphire Pharma | 15 M USD |
| 2021-04-12 | Antios Therapeutics | Altium Capital investment in Series B - Antios Therapeutics | 96 M USD |
| 2021-03-19 | X4 Pharmaceuticals | Altium Capital investment in Post-IPO Equity - X4 Pharmaceuticals | 55 M USD |
More informations about "Altium Capital"
Altium Capital - Crunchbase Investor Profile
Altium Capital is a healthcare investment firm focusing on the development of stage public mid-and small-cap equities. It focuses on identifying opportunities to invest in growth companies in the healthcare industry. Founded in 2017 by …See details»
Altium Capital Management | Team
Altium Capital Management team members. Chief Operating Officer. Prior to Altium, Mark was Partner Chief Administrative Officer of Visium Asset Management, a New York-based hedge …See details»
Altium Capital - LinkedIn
Altium Capital is an investment firm out of New York City focusing on funding healthcare initiatives and progressive therapies and treatments. The founder, Jacob Gottlieb, serves as CEO ...See details»
CEO of Altium Capital Management
Altium Capital is a Healthcare Investment Fund Founded by Jacob Gottlieb in 2017. Altium Capital is a New York City-based investment fund founded by Jacob Gottlieb. The fund focuses on healthcare investments, especially innovative …See details»
Altium Capital - Investments, Portfolio & Company Exits
Altium Capital 's most notable exits include Skye Bioscience, Sagimet Biosciences, and Cybin. Which industries has this organization had the most exits in? Show . Skye Bioscience Skye …See details»
Jacob Gottlieb - Chief Executive Officer - Altium Capital - LinkedIn
Dr. Jacob Gottlieb, MD, CFA, PRM, is the Founder and Chief Investment Officer of Altium Capital Management. He has over 25 years of experience in hedge funds, private equity, and venture …See details»
Altium Capital Management investment portfolio
Altium Capital Management General Information Company Description. Founded in 2017, Altium Capital Management is a private equity firm based in New York, New York. The firm prefers to make growth investments in private and public …See details»
Jacob Gottlieb - Altium Capital - ceocfointerviews.com
Jul 30, 2018 Jacob Gottlieb - Altium Capital, Jacob Gottlieb, CEO of Altium Capital: Investing, Philanthropy & Perseverance (from a native New Yorker), CEO Interviews 2018, Financial …See details»
Q&A with Jacob Gottlieb, CEO of Altium Capital
Jul 25, 2018 Jacob Gottlieb’s newest venture is Altium Capital, a healthcare investment firm he founded in order to help advance therapies for various diseases and conditions, including cancer, diabetes and Alzheimer’s Disease. …See details»
Altium Capital Management L.P. 13F annual report - wallmine
66 rows $222 billion Assets Under Management (AUM) As of 8th May 2024, Altium Capital Management L.P.’s top holding is 710,000 shares of Vera Therapeutics Inc currently worth …See details»
Altium Capital Investments, Portfolio & Acquisitions - Messari
Altium Capital. Altium Capital Management is an investment firm that invests in healthcare-focused technology companies. Founded in 2017. New York City, New York, United States. …See details»
Altium Capital - Contacts, Employees, Board Members
Altium Capital has 2 current employee profiles, including COO Mark Gottlieb. Contacts. Edit Contacts Section. Job Department. Protected Content. Chief Financial Officer. Non …See details»
Altium Capital Management LP Acquires New Stake in Elevai Labs Inc
On September 23, 2024, Altium Capital Management LP (Trades, Portfolio) marked a significant portfolio addition by purchasing 1,257,519 shares of Elevai Labs Inc (NASDAQ:ELAB).See details»
Altium Capital Company Profile: Service Breakdown & Team
Altium Capital was a corporate finance advisory firm founded in 1986 and based in London, United Kingdom. The firm's clients include dynamic growth companies, private and publicly …See details»
ALTIUM CAPITAL MANAGEMENT LP - WhaleWisdom.com
Altium Capital Management is based out of New York. Their last reported 13F filing for Q3 2024 included $339,708,332 in managed 13F securities and a top 10 holdings concentration of …See details»
Altium Capital - Company Database - Wall Street Oasis
Established for more than 20 years and privately owned, Altium is an international investment bank operating from eight offices across Europe. You will get a different perspective from us …See details»
Altium Capital Management | New York NY - Facebook
Altium Capital Management, New York, New York. 60 likes. ALTIUM CAPITAL: Healthcare hedge fund, focusing on development stage public mid- and small-cap equitSee details»
Farewell Altium: Everything you need to know about the $9 billion ...
Feb 16, 2024 Altium's board of directors unanimously recommended shareholders to accept the $68.50 cash per share takeover offer. The offer represents a 33.6% premium to its price prior …See details»
JPMorgan, Deutsche Bank tapped for $9.1bn Altium takeover
Feb 15, 2024 Altium was the target of a $40-a-share bid from US engineering software giant Autodesk in 2021. Autodesk walked away after the two technology businesses couldn’t agree …See details»